Closure of trading window for the quarter ending 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has informed BSE that its trading window will be closed from October 1, 2025, until 48 hours after the company declares its unaudited standalone financial results for the quarter ending September 30, 2025. During this period, insiders, designated persons, and their immediate relatives are prohibited from buying, selling, or pledging the company's shares. The board meeting date to approve the Q2 FY26 results will be announced separately. The notice has been signed by Managing Director Ghanshyam Dhananjay Gavali and is filed in compliance with SEBI's Insider Trading Regulations, 2015.
This is a routine, mandatory compliance announcement made every quarter before results are declared. It does not indicate any insider activity and is unlikely to have any direct impact on the stock price. Investors should watch for the upcoming Q2 results announcement, which will be the next material event for the stock.